Generation of retroviral vector for clinical studies using transient transfection

Human Gene Therapy

Volumn 10, Issue 1, 1999, Pages 123-132

  Yang, Shiaolan ^a,b   Delgado, Rafael ^a   King, Steven R ^a,c   Woffendin, Clive ^a,c   Barker, Christopher S ^a   Yang, Zhi Yong ^a,c   Xu, Ling ^a   Nolan, Garry P ^d   Nabel, Gary J ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b EVANSTON HOSPITAL   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GREEN FLUORESCENT PROTEIN; VIRUS PROTEIN; VIRUS VECTOR;

ARTICLE; CLINICAL STUDY; COST EFFECTIVENESS ANALYSIS; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; GIBBON LEUKEMIA VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RETROVIRUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRION;

ANIMALS; ANTIGENS, CD4; BETA-GALACTOSIDASE; BLOOD CELLS; CELL LINE; DOGS; FLOW CYTOMETRY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MICE; PLASMIDS; RETROVIRIDAE; T-LYMPHOCYTES; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0032945086     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950019255     Document Type: Article

References (42)

1. ANDERSON, W.F. (1984). Prospects for human gene therapy. Science 226, 401.
2. BALTIMORE, D. (1970). RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature (London) 226, 1209-1211.
3. BAUM, C., ITOH, K., MEYER, J., LAKER, C., ITO, Y., and OSTERTAG, W. (1997). The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF. J. Virol. 71, 6323-6331.
4. BONYHADI, M.L., MOSS, K., VOYTOVICH, A., AUTEN, J., KALFOGLOU, C., PLAVEC, I., FORESTELL, S., SU, L., BOHNLEIN, E., and KANESHIMA, H. (1997). RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J. Virol. 71, 4707-4716.
5. BUNNELL, B.A., MUUL, L.M., DONAHUE, R.E., BLAESE, R.M., and MORGAN, R.A. (1995). High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 7739-7743.
6. CHALLITA, P.M., SKELETON, D., EL-KHOUEIRY, A., YU, S.J., WEINBERG, K., and KOHN, D.B. (1995). Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol. 69, 748-755.
7. CHAMBERS, C.A., and ALLISON, J.P. (1997). Co-stimulation in T cell responses. Curr. Opin. Immunol. 9, 396-404.
8. CULLEN, B.R. (1991). Regulation of HIV-1 gene expression. FASEB J. 5, 2361-2368.
9. CULLEN, B.R., and GREENE, W.C. (1989). Regulatory pathways governing HIV-1 replication. Cell 58, 423-426.
10. EMBRETSON, J.E., and TEMIN, H.M. (1987). Transcription from a spleen necrosis virus 5′ long terminal repeat is suppressed in mouse cells. J. Virol. 61, 3454-3462.
11. EMI, N., FRIEDMANN, T., and YEE, J.K. (1991). Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J. Virol. 65, 1202-1207.
12. FINER, M.H., DULL, T.J., QIN, L., FARSON, D., and ROBERTS, M.R. (1994). Kat: A high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 83, 43-50.
13. KAVANAUGH, M.P., MILLER, D.G., ZHANG, W., LAW, W., KOZAK, S.L., KABAT, D., and MILLER, A.D. (1994). Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. U.S.A. 91, 7071-7075.
14. KINSELLA, T.M., and NOLAN, G.P. (1996). Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7, 1405-1413.
15. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 272, 1939-1943.
16. LIU, J., WOFFENDIN, C., YANG, Z., and NABEL, G.J. (1994). Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells. Gene Ther. 1, 32-37.
17. LUND, A.H., DUCH, M., and PEDERSEN, F.S. (1996). Transcriptional silencing of retroviral vectors. J. Biomed. Sci. 3, 365-378.
18. MEBATSION, T., FINKE, S., WEILAND, F., and CONZELMANN, K.K. (1997). A CXCR4/CD4 pseudotype rhabdovirus that selectively infects HIV-1 envelope protein-expressing cells. Cell 90, 841-847.
19. MILLER, A.D. (1990). Retrovirus packaging cells. Hum. Gene Ther. 1, 5-14.
20. MILLER, A.D. (1996). Cell-surface receptors for retroviruses and implications for gene transfer. Proc. Natl. Acad. Sci. U.S.A. 93, 11407-11413.
21. MILLER, A.D., GARCIA, J.V., VON SUHR, N., LYNCH, C.M., WILSON, C., and EIDEN, M. (1991). Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65, 2220-2224.
22. NABEL, E.G., PLAUTZ, G., and NABEL, G.J. (1990). Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 249, 1285-1288.
23. NALDINI, L., BLOMER, U., GAGE, F.H., TRONO, D., and VERMA, I.M. (1996a). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 93, 11382-11388.
24. NALDINI, L., BLOMER, U., GALLAY, P., ORY, D., MULLIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996b). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
25. NAVIAUX, R.K., COSTANZI, E., HAAS, M., and VERMA, I.M. (1996). The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70, 5701-5705.
26. PEAR, W.S., NOLAN, G.P., SCOTT, M.L., and BALTIMORE, D. (1993). Production of high-liter helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. U.S.A. 90, 8392-8396.
27. RANGA, U., WOFFENDIN, C., YANG, Z., XU, L., VERMA, S., LITTMAN, D.R., and NABEL, G.J. (1997). Cell and viral regulatory elements enhance the expression and function of a human immunodeficiency virus inhibitory gene. J. Virol. 71, 7020-7029.
28. RANGA, U., WOFFENDIN, C., VERMA, S., XU, L., JUNE, C.H., BISHOP, D.K., and NABEL, G.J. (1998). Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals. Proc. Natl. Acad. Sci. U.S.A. 95, 1201-1206.
29. RIDDELL, S.R., ELLIOTT, M., LEWINSOHN, D.A., GILBERT, M.J., WILSON, L., MANLEY, S.A., LUPTON, S.D., OVERELL, R.W., REYNOLDS, T.C., COREY, L., and GREENBERG, P.D. (1996). T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Med. 2, 216-223.
30. ROBBINS, P.B., YU, X.-J., SKELTON, D.M., PEPPER, K.A., WASSERMAN, R.M., ZHU, L., and KOHN, D.B. (1997). Increased probability of expression from modified retroviral vectors in embrional stem cells and embryonal carcinoma cells. J. Virol. 71, 9466-9474.
31. SANES, J.R., RUBENSTEIN, J.L., and NICOLAS, J.F. (1986). Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5, 3133-3142.
32. SCHLEGEL, R., WILLINGHAM, M.C., and PASTAN, I.H. (1982). Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells. J. Virol. 43, 871-875.
33. SCHNELL, M.J., JOHNSON, J.E., BUONOCORE, L., and ROSE, J.K. (1997). Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell 90, 849-857.
34. SONEOKA, Y., CANNON, P.M., RAMSDALE, E.E., GRIFFITHS, J.C., ROMANO, G., KINGSMAN, S.M., and KINGSMAN, A.J. (1995). A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23, 628-633.
35. TAKEUCHI, Y., COSSET, F.L., LACHMANN, P.J., OKADA, H., WEISS, R.A., and COLLINS, M.K. (1994). Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J. Virol. 68, 8001-8007.
36. TEMIN, H.M., and MIZUTANI, S. (1970). RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (London) 226, 1211-1213.
37. VERMA, I.M., and SOMIA, N. (1997). Gene therapy-promises, problems and prospects. Nature (London) 389, 239-242.
38. WOFFENDIN, C., YANG, Z., UDAYKUMAR, XU, L., YANG, N., SHEEHY, M.J., and NABEL, G.J. (1994). Non-viral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc. Natl. Acad. Sci. U.S.A. 91, 11581-11585.
39. WOFFENDIN, C., RANGA, U., and NABEL, G.J. (1996a). Development of molecular genetic interventions for HIV infection. In: Current Protocols in Human Genetics (J. Wiley & Sons, New York) Section 1.3.
40. WOFFENDIN, C., RANGA, U., YANG, Z., XU, L., and NABEL, G.J. (1996b). Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc. Natl. Acad. Sci. U.S.A. 93, 2889-2894.
41. YANG, S., and TEMIN, H.M. (1994). A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J. 13, 713-726.
42. YEE, J.K., MIYANOHARA, A., LAPORTE, P., BOVIC, K., BURNS, J.C., and FRIEDMAN, T. (1994). A general method for the generation of high titer, pantropic retroviral vectors: Highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 91, 9564-9568.